Quercetin mitochondriotropic derivatives antagonize nitrate tolerance and endothelial dysfunction of isolated rat aorta rings

Planta Medica

Volumn 79, Issue 6, 2013, Pages 465-467

  Durante, Miriam ^a   Sgaragli, Giampietro ^a   Biasutto, Lucia ^b,c   Mattarei, Andrea ^b,c   Fusi, Fabio ^a  

^a UNIVERSITY OF SIENA   (Italy)

^b CNR   (Italy)

^c UNIVERSITY OF PADOVA   (Italy)

Author keywords

endothelial dysfunction; glyceryl trinitrate tolerance; quercetin; rat aorta rings

Indexed keywords

3 (4 O TRIPHENYLPHOSPHONIUMBUTYL) QUERCETIN IODIDE; 3',4',5,7 TETRA ACETYL 3 (4 O TRIPHENYLPHOSPHONIUMBUTYL) QUERCETIN IODIDE; ACETYLCHOLINE; GLYCERYL TRINITRATE; QUERCETIN DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENDOTHELIAL DYSFUNCTION; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; RAT; VASCULAR RING;

ACETYLCHOLINE; ANIMALS; AORTA; ENDOTHELIUM, VASCULAR; NITROGLYCERIN; OXIDATIVE STRESS; QUERCETIN; RATS;

RATTUS;

EID: 84876687073     PISSN: 00320943     EISSN: 14390221     Source Type: Journal    
DOI: 10.1055/s-0032-1328293     Document Type: Article

References (22)

1. Wenzel P., Mollnau H., Oelze M., Schulz E., Wickramanayake J. M., Müller J., Schuhmacher S., Hortmann M., Baldus S., Gori T., Brandes R. P., Münzel T., Daiber A. First evidence for a crosstalk between mitochondrial and NADPH oxidase-derived reactive oxygen species in nitroglycerin-triggered vascular dysfunction. Antioxid Redox Signal: 2008; 10 1435 1447
2. Hink U., Daiber A., Kayhan N., Trischler J., Kraatz C., Oelze M., Mollnau H., Wenzel P., Vahl C. F., Ho K. K., Weiner H., Münzel T. Oxidative inhibition of the mitochondrial aldehyde dehydrogenase promotes nitroglycerin tolerance in human blood vessels. J Am Coll Cardiol: 2007; 50 2226 2232 (Pubitemid 350166814)
3. Murphy M. P., Smith R. A. Targeting antioxidants to mitochondria by conjugation to lipophilic cations. Annu Rev Pharmacol Toxicol: 2007; 47 629 656
4. Green K., Brand M. D., Murphy M. P. Prevention of mitochondrial oxidative damage as a therapeutic strategy in diabetes. Diabetes: 2004; 53 110 118
5. Yeates R. A., Schmid M. Total prevention of the development of in vitro tolerance to organic nitrates. Experiments with antioxidants. Arzneimittelforschung: 1992; 42 297 302
6. Mattarei A., Biasutto L., Marotta E., De Marchi U., Sassi N., Garbisa S., Zoratti M., Paradisi C. A mitochondriotropic derivative of quercetin: a strategy to increase the effectiveness of polyphenols. Chembiochem: 2008; 9 2633 2642
7. Daiber A., Wenzel P., Oelze M., Münzel T. New insights into bioactivation of organic nitrates, nitrate tolerance and cross-tolerance. Clin Res Cardiol: 2008; 97 12 20
8. Suri S., Liu X. H., Rayment S., Hughes D. A., Kroon P. A., Needs P. W., Taylor M. A., Tribolo S., Wilson V. G. Quercetin and its major metabolites selectively modulate cyclic GMP-dependent relaxations and associated tolerance in pig isolated coronary artery. Br J Pharmacol: 2010; 159 566 575
9. Fiorani M., Guidarelli A., Blasa M., Azzolini C., Candiracci M., Piatti E., Cantoni O. Mitochondria accumulate large amounts of quercetin: prevention of mitochondrial damage and release upon oxidation of the extramitochondrial fraction of the flavonoid. J Nutr Biochem: 2010; 21 397 404
10. Manach C., Scalbert A., Morand C., Remesy C., Jimenez L. Polyphenols: food sources and bioavailability. Am J Clin Nutr: 2004; 79 727 747 (Pubitemid 41103873)
11. Williamson G., Manach C. Bioavailability and bioefficacy of polyphenols in humans. II. Review of 93 intervention studies. Am J Clin Nutr: 2005; 81 243S 255S
12. Lin H. C., Cheng T. H., Chen Y. C., Juan S. H. Mechanism of heme oxygenase-1 gene induction by quercetin in rat aortic smooth muscle cells. Pharmacology: 2004; 71 107 112
13. Wenzel P., Oelze M., Coldewey M., Hortmann M., Seeling A., Hink U., Mollnau H., Stalleicken D., Weiner H., Lehmann J., Li H., Forstermann U., Münzel T., Daiber A. Heme oxygenase-1: a novel key player in the development of tolerance in response to organic nitrates. Arterioscler Thromb Vasc Biol: 2007; 27 1729 1735 (Pubitemid 47207167)
14. Münzel T., Daiber A., Gori T. Nitrate therapy: new aspects concerning molecular action and tolerance. Circulation: 2011; 123 2132 2144
15. Cai H., Harrison D. G. Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ Res: 2000; 87 840 844
16. Félétou M., Vanhoutte P. M. Endothelial dysfunction: a multifaceted disorder (The Wiggers Award Lecture). Am J Physiol Heart Circ Physiol: 2006; 291 H985 H1002 (Pubitemid 44343640)
17. Schulz E., Jansen T., Wenzel P., Daiber A., Münzel T. Nitric oxide, tetrahydrobiopterin, oxidative stress, and endothelial dysfunction in hypertension. Antioxid Redox Signal: 2008; 10 1115 1126 (Pubitemid 351451710)
18. Smith R. A., Murphy M. P. Mitochondria-targeted antioxidants as therapies. Discov Med: 2011; 11 106 114
19. Lopez-Lopez G., Moreno L., Cogolludo A., Galisteo M., Ibarra M., Duarte J., Lodi F., Tamargo J., Perez-Vizcaino F. Nitric oxide (NO) scavenging and NO protecting effects of quercetin and their biological significance in vascular smooth muscle. Mol Pharmacol: 2004; 65 851 859 (Pubitemid 38420490)
20. phox induced by angiotensin II in rat aorta. J Nutr: 2007; 137 910 915 (Pubitemid 46596886)
21. Steffen Y., Gruber C., Schewe T., Sies H. Mono-O-methylated flavanols and other flavonoids as inhibitors of endothelial NADPH oxidase. Arch Biochem Biophys: 2008; 469 209 219 (Pubitemid 50008450)
22. Fusi F., Marazova K., Pessina F., Gorelli B., Valoti M., Frosini M., Sgaragli G. P. On the mechanisms of the antispasmodic action of some hindered phenols in rat aorta rings. Eur J Pharmacol: 2000; 394 109 115 (Pubitemid 30193296)